Trial Profile
A multi-centre, randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of two concentrations of PKB171 against placebo in couples with asthenozoospermia who wish to conceive.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs Pentoxifylline (Primary)
- Indications Asthenozoospermia
- Focus Therapeutic Use
- Sponsors Prokrea
- 15 Jul 2019 Status changed from recruiting to discontinued.
- 24 Mar 2017 New trial record